James H. SabryGlobal Head, Pharma Partnering at Roche
James Sabry is Global Head, Roche Pharma Partnering, a role that combines the partnering functions across the Roche pharmaceuticals business. Prior to this new role Sabry served as Senior Vice President, Genentech Partnering, where he oversaw both Business Development and Alliance Management groups. Sabry grew up in Toronto, Canada and received an M.D. from Queen’s University in Kingston, Canada. Completing an internship in internal medicine at Toronto Western Hospital, he moved to Harvard Medical School where he completed a residency in Neurology, being named chief resident in Neurology in 1987. James was President and CEO of Cytokinetics until 2007. During that time, he grew the company from inception to over 200 employees and took the company public on NASDAQ in 2004. In 2007, he became Chairman of the Board of Directors and a member of their Scientific Advisory Board. In 2008, he became President and CEO of Arete Therapeutics, a company focused on the discovery and development of therapeutics for diabetes.